Trial Profile
An Open-label, Randomized, Active-controlled Study to Compare the Effect of 16 Weeks Treatment With Vildagliptin to Pioglitazone as add-on Therapy to Metformin in Type 2 Diabetic Patients Inadequately Controlled With Metformin Monotherapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary) ; Metformin; Pioglitazone
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 10 Jul 2013 New trial record